# Jubilant HollisterStier General Partnership, Quebec, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/jubilant-hollisterstier-general-partnership/fd593d8a-dc2a-4d60-b14d-bbb95e4c0011

> Inspection records and compliance data for Jubilant HollisterStier General Partnership in Quebec, H9H. 11 FDA inspections on record (3 OAI), 4 Form 483s, 2 warning letters, last inspected November 03, 2025.

---

## Details

- Name: Jubilant HollisterStier General Partnership
- FEI Number: 3001623073
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: 16751 Rte Transcanadienne
- Address Line 2: Kirkland
- City: Quebec
- State: H9H
- Zip Code: 4J4
- Country Name: Canada
- Address: 16751 Rte Transcanadienne Kirkland, Quebec, H9H 4J4, Canada
- Country: Canada

## Related Documents

- [WARNING_LETTER - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/warning_letter/jubilant-hollisterstier-general-partnership/670ebeea-f337-45a7-9253-ca0202eb4a9e) — source: FDA, date: November 3, 2025
- [483 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/2769eb91-40eb-43ba-bb67-bbe38104b6ea) — source: FDA, date: November 3, 2025
- FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03 — classification: Official Action Indicated (OAI), source: FDA, date: November 3, 2025
- [FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/c7bc60d3-d5f8-4b4e-ac62-9a1d1019ea3c) — classification: Official Action Indicated (OAI), source: FDA, date: November 3, 2025
- FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03 — source: FDA, date: November 3, 2025
- FDA Inspection 1289886 - Jubilant HollisterStier General Partnership - 2025-11-03 — classification: Official Action Indicated (OAI), source: FDA, date: November 3, 2025
- [EIR - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/eir/jubilant-hollisterstier-general-partnership/a03c58f7-f020-4ed1-a496-915854d6e2e1) — source: FDA, date: June 14, 2024
- [483 - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/e9b167e3-9b61-452c-9c8b-ad02c007f690) — source: FDA, date: June 14, 2024
- [FDA Inspection 1242347 - Jubilant HollisterStier General Partnership - 2024-06-14](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/11f27799-0652-4128-a5b0-54a5bdd42527) — classification: Official Action Indicated (OAI), source: FDA, date: June 14, 2024
- FDA Inspection 1242347 - Jubilant HollisterStier General Partnership - 2024-06-14 — classification: Official Action Indicated (OAI), source: FDA, date: June 14, 2024
- Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #82684 - 2024-01-22 — source: Canada, date: January 22, 2024
- [483 - Jubilant HollisterStier General Partnership - 2023-02-28](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/f3b980c5-7eb1-4481-9eff-7a8d0e6dfe67) — source: FDA, date: February 28, 2023
- [EIR - Jubilant HollisterStier General Partnership - 2023-02-28](https://www.keypedia.com/records/eir/jubilant-hollisterstier-general-partnership/1937548f-0fee-482d-844a-a4acc7d679b1) — source: FDA, date: February 28, 2023
- [FDA Inspection 1199491 - Jubilant HollisterStier General Partnership - 2023-02-28](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/c1599cc3-56be-406b-b794-fe21b9342cf4) — source: FDA, date: February 28, 2023
- FDA Inspection 1181741 - Jubilant HollisterStier General Partnership - 2022-10-07 — classification: No Action Indicated (NAI), source: FDA, date: October 7, 2022
- Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #77384 - 2021-10-12 — source: Canada, date: October 12, 2021
- Canada Inspection - Jubilant HollisterStier General Partnership - Inspection #73266 - 2019-12-04 — source: Canada, date: December 4, 2019
- [483 - Jubilant HollisterStier General Partnership - 2018-06-01](https://www.keypedia.com/records/483/jubilant-hollisterstier-general-partnership/614c1fb7-5a4f-4731-9eeb-c77885572e9d) — source: FDA, date: June 1, 2018
- [FDA Inspection 1054645 - Jubilant HollisterStier General Partnership - 2018-06-01](https://www.keypedia.com/records/fda_inspections/jubilant-hollisterstier-general-partnership/f923c34a-24ff-4825-ac3c-25d24709e0a4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- FDA Inspection 1054645 - Jubilant HollisterStier General Partnership - 2018-06-01 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018

## Related Companies

- [Baxter Oncology GmbH](https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06)
- [Catalent Indiana, LLC](https://www.keypedia.com/companies/catalent-indiana-llc/3422c8c4-978a-45ba-962b-b00002fffd6d)
- [Resilience Biotechnologies, Inc.](https://www.keypedia.com/companies/resilience-biotechnologies-inc/b3d6ed53-42d5-4c02-adca-c777bb39151c)
- [Groupe Parima Inc.](https://www.keypedia.com/companies/groupe-parima-inc/49e213ea-3ec6-4535-adaf-c0b6c7d25a23)
- [Confab Laboratories Inc.](https://www.keypedia.com/companies/confab-laboratories-inc/cae88900-5d2c-47b7-aedc-3931dd4f8310)
- [Delpharm Montreal Inc.](https://www.keypedia.com/companies/delpharm-montreal-inc/8d8c8dde-c584-4148-909c-c3c1db7c8268)
- [Catalent Ontario Limited](https://www.keypedia.com/companies/catalent-ontario-limited/0d441910-9eee-4011-b5e8-c989fb788c69)
- [Pillar5 Pharma Inc.](https://www.keypedia.com/companies/pillar5-pharma-inc/8b94b834-f2da-4821-9ddc-6795a5e6d6f0)
- [E-Z-EM Canada, Inc](https://www.keypedia.com/companies/e-z-em-canada-inc/de31e064-9679-4127-b65f-39ecba03c801)
- [Viva Pharmaceutical Inc](https://www.keypedia.com/companies/viva-pharmaceutical-inc/0e5d1aa3-8369-4a0d-91b7-e516415fb219)

## Related Officers

- [Michael D. Smedley](https://www.keypedia.com/people/michael-d-smedley/6bc2c49a-be81-4769-9185-28538aa5c105)
- [Investigator](https://www.keypedia.com/people/brett-r-havranek/6a4eaba0-a8df-40f6-a21d-45ec5a0e9f6b)
- [Investigator ](https://www.keypedia.com/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Investigator](https://www.keypedia.com/people/rafeeq-a-habeeb/ac58c0b7-bd42-4037-8ccb-bf0351b7744f)